<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-1OE2JBHS</identifier><date>2014</date><creator>Pal, Marjetka</creator><relation>documents/doc/1/URN_NBN_SI_doc-1OE2JBHS_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1OE2JBHS_001.txt</relation><format format_type="issue">2</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 93-100</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">28104487</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1OE2JBHS</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antimikotiki</subject><subject language_type_id="slv">dermatologija</subject><subject language_type_id="slv">glivične okužbe</subject><subject language_type_id="slv">mikoze</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Možnosti zdravljenja najpogostejših dermatomikoz pri odraslih in mladostnikih</title><title>Treatment possibilities for the most common dermatomycoses in adults and adolescents</title></Record>